Kipnis adds
IGF-1 LR3 is sold for laboratory research use only
The third generation are prolonged-acting GLP-1 analogs, with sustained action requiring a dosing regimen ranging from once-weekly to once-monthly injection (e.g., exenatide-LAR or exenatide once weekly)
Yuk H, Abdullah M, Kim DH, Lee H, Lee SJ
In vitro , iron chelation with deferoxamine mimics these effects, inducing dose-dependent eryptosis in human erythrocytes, confirming iron depletion per se primes RBCs for apoptotic death (Kempe et al., 2006)
Potential Side Effects As with any injection therapy, some patients may experience minor injection-site reactions including redness, mild pain, itching, or swelling